Singleplex Immunoassay Market

By Product And Service;

Consumables, Instruments, and Others

By Type;

Protein-Based Assays, Nucleic Acid Based Assays, Cell-Based Assays, and Others

By Technology;

Flow Cytometry, Fluorescence Detection, and Others

By End-User;

Pharmaceuticals & Biotechnology Companies, Hospital & Research Institutes, Reference Laboratories, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn133510363 Published Date: August, 2025 Updated Date: September, 2025

Singleplex Immunoassay Market Overview

Singleplex Immunoassay Market (USD Million)

Singleplex Immunoassay Market was valued at USD 3284.59 million in the year 2024. The size of this market is expected to increase to USD 4938.81 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.0%.


Singleplex Immunoassay Market

*Market size in USD million

CAGR 6.0 %


Study Period2025 - 2031
Base Year2024
CAGR (%)6.0 %
Market Size (2024)USD 3284.59 Million
Market Size (2031)USD 4938.81 Million
Market ConcentrationMedium
Report Pages342
3284.59
2024
4938.81
2031

Major Players

  • Abbott Laboratories
  • Danaher Corporation (Beckman Coulter)
  • Quidel Corporation
  • Ortho Clinical Diagnostics
  • Sysmex Corporation
  • Bio-Rad Laboratories, Inc.
  • Becton, Dickinson, and Company
  • F. Hoffmann-La Roche AG
  • Thermo Fisher Scientific, Inc.
  • Siemens Healthinners

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Singleplex Immunoassay Market

Fragmented - Highly competitive market without dominant players


The Singleplex Immunoassay Market is experiencing strong growth as healthcare systems prioritize accurate diagnostic testing. Nearly 68% of laboratories prefer singleplex assays for their ability to deliver highly specific biomarker detection with minimal cross-reactivity. This precision ensures consistent outcomes, making them indispensable in modern diagnostic practices.

Increased Application in Drug Research
More than 60% of biopharmaceutical companies utilize singleplex immunoassays during drug development to validate biomarker activity. Their reproducibility and standardized protocols enhance research accuracy, while their role in assessing safety and efficacy strengthens their position in both academic and commercial drug pipelines.

Essential Tool for Chronic Illness Care
Chronic diseases such as cancer and autoimmune disorders account for nearly 72% of diagnostic needs. Singleplex immunoassays support precise biomarker quantification, enabling better disease monitoring and treatment personalization. Their ability to guide targeted therapeutic strategies makes them vital in patient management.

Technological Innovations Driving Growth
Continuous advancements in assay kits and detection systems have boosted sensitivity by 45% while reducing turnaround times. Integration with automation and high-throughput platforms allows laboratories to achieve faster and more efficient testing, positioning singleplex assays as a crucial element in modern diagnostic workflows.

Cost Benefits Expanding Market Reach
Affordability remains a major driver, with nearly 58% of laboratories adopting singleplex assays due to their lower reagent requirements and ease of interpretation. Compared to multiplex formats, these assays are more cost-efficient, making them particularly appealing to small and mid-sized laboratories seeking reliable yet economical solutions.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product And Service
    2. Market Snapshot, By Type
    3. Market Snapshot, By Technology
    4. Market Snapshot, By End-User
    5. Market Snapshot, By Region
  4. Singleplex Immunoassay Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Prevalence of Chronic Diseases and Infectious Diseases
        2. Advancements in Personalized Medicine and Targeted Therapies
        3. Technological Advancements and Improvements in Assay Sensitivity
      2. Restraints
        1. High Costs of Advanced Immunoassay Platforms
        2. Competition from Multiplex Immunoassays
        3. Regulatory Hurdles and Long Approval Processes
      3. Opportunities
        1. Growth of Point-of-Care (POC) Diagnostics
        2. Rising Adoption of Home Diagnostics
        3. Expanding Applications in Biomarker Discovery and Drug Development
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Singleplex Immunoassay Market, By Product And Service, 2021 - 2031 (USD Million)
      1. Consumables
      2. Instruments
      3. Others
    2. Singleplex Immunoassay Market, By Type, 2021 - 2031 (USD Million)
      1. Protein-Based Assays
      2. Nucleic Acid Based Assays
      3. Cell-Based Assays
      4. Others
    3. Singleplex Immunoassay Market, By Technology, 2021 - 2031 (USD Million)
      1. Flow Cytometry
      2. Fluorescence Detection
      3. Others.
    4. Singleplex Immunoassay Market,By End User,2021 - 2031 (USD Million)
      1. Pharmaceuticals & Biotechnology Companies
      2. Hospital & Research Institutes
      3. Reference Laboratories
      4. Others
    5. Singleplex Immunoassay Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscapes
    1. Company Profiles
      1. Abbott Laboratories
      2. Danaher Corporation (Beckman Coulter)
      3. Quidel Corporation
      4. Ortho Clinical Diagnostics
      5. Sysmex Corporation
      6. Bio-Rad Laboratories, Inc.
      7. Becton, Dickinson, and Company
      8. F. Hoffmann-La Roche AG
      9. Thermo Fisher Scientific, Inc.
      10. Siemens Healthinner
  7. Analyst Views
  8. Future Outlook of the Market